NCT00495729View on ClinicalTrials.gov

15-Day Repeated-Dose Study With SB-649868 And Its Interaction With CYP3A4 Isoenzyme In Healthy Male Subjects.

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

April 18, 2007

Primary Completion Date

August 4, 2007

Study Completion Date

August 4, 2007

Conditions
Sleep Initiation and Maintenance Disorders
Interventions
DRUG

SB-649868

Subjects will receive SB-649868 5 mg, 25 mg tablets orally 1 hour prior to simvastatin administration.

DRUG

Placebo

Subjects will receive matching placebo tablets to SB-649868 orally 1 hour prior to simvastatin administration.

DRUG

Simvastatin

Subjects will receive Simvastatin 10 mg tablets orally.

Trial Locations (1)

14050

GSK Investigational Site, Berlin

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00495729 - 15-Day Repeated-Dose Study With SB-649868 And Its Interaction With CYP3A4 Isoenzyme In Healthy Male Subjects. | Biotech Hunter | Biotech Hunter